跳至主要内容
临床试验/ISRCTN51398568
ISRCTN51398568已完成不适用

Prophylactic infusion of CD4 positive donor lymphocytes early after T-cell depleted stem cell transplantatio

eiden University Medical Centre (Netherlands)0 个研究点目标入组 60 人开始时间: 2008年6月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Both males and females
  • 2. Age from 18 to 70 years
  • 3. Patients with acute myeloid leukaemia (AML), myelodysplasia (MDS), acute lymphocytic leukaemia (ALL), chronic myeloid leukaemia (CML) in accelerated phase or blastic transformation, chronic lymphocytic leukaemia (CLL), multiple myeloma (MM) or aggressive lymphoma, who received an allogeneic stem cell transplantation.

排除标准

  • 1. Systemic immunosuppressive treatment
  • 2. Progressive Graft Versus Host Disease (GVHD)
  • 3. GVHD of the skin greater than grade 2
  • 4. Progressive disease needing cytoreductive treatment

研究者

发起方
eiden University Medical Centre (Netherlands)

相似试验